Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate

• Κύριοι συγγραφείς: Douglas J. Taylor (Συγγραφέας), Vera Halpern (Συγγραφέας), Vivian Brache (Συγγραφέας), Luis Bahamondes (Συγγραφέας), Jeffrey T. Jensen (Συγγραφέας), Laneta J. Dorflinger (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Elsevier, 2022-01-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Objectives: To characterize the relationship between serum medroxyprogesterone acetate (MPA) concentrations and ovulation suppression, and to estimate the risk of ovulation for investigational subcutaneous regimens of Depo-Provera CI (Depo-Provera) and Depo-subQ Provera 104 (Depo-subQ). Study Design...